Skip to main content
HEALIUS LIMITED logo

HEALIUS LIMITED — Investor Relations & Filings

Ticker · HLS ISIN · AU0000033359 LEI · 529900MBZK3SLWK8SJ55 ASX Human health and social work activities
Open in API
Filings indexed 2,292 across all filing types
Latest filing 2024-10-14 AGM Information
Country AU Australia
Listing ASX HLS

About HEALIUS LIMITED

https://www.healius.com.au

Healius Limited is a leading healthcare service provider specializing in pathology and diagnostic imaging services. The company operates an extensive network of pathology laboratories and collection centers, providing diagnostic testing across various medical disciplines including biochemistry, hematology, and microbiology. Its diagnostic imaging division offers a comprehensive range of services such as X-rays, ultrasounds, CT scans, and MRIs through a network of community-based and hospital-integrated clinics. Healius focuses on delivering high-quality diagnostic insights to healthcare professionals and patients, leveraging advanced technology and a large-scale infrastructure to support clinical decision-making and patient care outcomes.

Recent filings

Filing Released Lang Actions
2024 HLS AGM Letter to Shareholders 5 pages 303.0KB
AGM Information Classification · 95% confidence The document is a letter dated 15 October 2024 addressed to shareholders regarding the Healius Limited Annual General Meeting (AGM) scheduled for 15 November 2024. It provides details on how to attend, participate, vote, and access the Notice of Meeting and other AGM materials. The content focuses on the logistics and participation instructions for the AGM rather than presenting financial data, management discussion, or voting results. There is no indication that this document contains the actual AGM materials or financial reports, but rather it serves as an invitation and informational notice about the upcoming AGM. Therefore, this document fits the category of AGM Information (AGM-R), which includes presentations and materials shared during or about the AGM, especially notices and participation instructions.
2024-10-14 English
Becoming a substantial holder 15 pages 1.6MB
Major Shareholding Notification Classification · 100% confidence The document is titled 'Form 603 Corporations Act 2001 Section 671B Notice of initial substantial holder' and details the substantial shareholding of State Street Corporation and its subsidiaries in Healius Limited. It includes voting power percentages, relevant interests, registered holders, consideration paid, associates, and addresses. This form is a regulatory filing notifying the market and regulators of a substantial shareholding crossing a threshold, as required under Australian Corporations Act. It is not an annual report, earnings release, management report, or any other financial or governance report. It is a notification of major shareholding changes.
2024-10-03 English
Notification of cessation of securities - HLS 5 pages 17.0KB
Regulatory Filings Classification · 95% confidence The document is titled 'Appendix 3H - Notification of cessation of securities' and details the lapse or expiry of certain securities (performance rights, options, service rights) for Healius Limited. It provides specific information about securities that have ceased, including quantities and cessation dates. The document is a formal announcement to the ASX about changes in the company's issued capital due to cessation of securities. It does not contain financial statements, management discussion, or detailed financial results. It is a regulatory announcement about changes in securities status, fitting the category of Regulatory Filings (RNS) as it does not fit other more specific categories like Share Issue/Capital Change (SHA) which typically involves new issues or capital increases rather than cessation or lapsing of securities.
2024-10-02 English
Ceasing to be a substantial holder 8 pages 787.8KB
Major Shareholding Notification Classification · 95% confidence The document is titled 'Form 605' and is a 'Notice of ceasing to be a substantial holder' under the Corporations Act 2001, Section 671B. It details changes in relevant interests of a substantial holder (State Street Corporation and subsidiaries) in the voting securities of Healius Limited. The content includes dates of changes, nature of changes, and securities affected, which is typical for a major shareholding notification. There is no financial performance data, earnings information, or management discussion. The document is regulatory in nature, specifically reporting changes in substantial shareholding. Therefore, it fits the category of Major Shareholding Notification (MRQ). The document length is substantial and contains detailed transaction data, supporting a high confidence in classification.
2024-10-01 English
Sale of Lumus Imaging to Affinity Equity Partners 3 pages 231.1KB
Capital/Financing Update Classification · 95% confidence The document is an ASX announcement dated 23 September 2024 regarding the sale of a subsidiary, Lumus Imaging, by Healius Limited to Affinity Equity Partners. It details the terms of the transaction, strategic rationale, expected completion timeline, and financial implications. The content focuses on a capital transaction involving divestment and use of proceeds, including debt reduction and shareholder returns. There is no detailed financial report or earnings data, nor is it a regulatory certification or voting result. The document is a corporate announcement about a significant financing and capital structure event. Therefore, the most appropriate classification is Capital/Financing Update (CAP). The document length (7628 characters) supports it being a full announcement rather than a brief notice or report publication announcement.
2024-09-22 English
Lumus Imaging Sale Presentation 8 pages 392.4KB
Investor Presentation Classification · 100% confidence The document is an investor presentation dated 23 September 2024, discussing the sale of Lumus Imaging by Healius Limited. It includes detailed financial metrics, strategic rationale, pro forma impacts, capital management plans, and transaction details. The content is structured as a presentation aimed at investors, focusing on financials, strategy, and market position related to the sale. There is no indication that this is a full annual or interim report, audit report, or regulatory filing. The document is not a brief factsheet or a voting result announcement. It is clearly a detailed investor presentation about a significant transaction and its implications. Therefore, the appropriate classification is Investor Presentation (IP).
2024-09-22 English

Browse filings by year

25 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.